OncoReview https://journalsmededu.pl/index.php/OncoReview <p><span lang="en-GB">"OncoReview" (abbr.: "OncoReview") is a peer-reviewed scientific quarterly publishing papers in: cardiooncology oncology, cardiological aspects of oncology and hematology.</span><a name="_GoBack"></a><span lang="en-GB">The journal is on the list of the Polish Ministry of Science and Higher Education. For publishing the article, the author receives </span><span lang="en-GB">XX</span><span lang="en-GB"> points.&nbsp;</span><span lang="en-GB">We encourage you to submit: original papers, review articles, case reports, rapid communication, research letters, hypotheses, meeting proceedings, letter to the editor. We guarantee fast publication. </span><span lang="en-GB">There are no submission or processing charges.</span></p> en-US <p><span lang="en-GB"><em>Submitting a paper is tantamount to an automatic and free-of-charge transfer of copyright (to publish and distribute the submitted material in all forms and fields of exploitation known now and developed in the future) to the Publisher, on condition that those materials are accepted for publication.</em></span></p> <p><span lang="en-GB"><em>The names and e-mail addresses submitted with the article will be used exclusively for editorial purposes of this journal and correspondence, and will not be made available for any other purpose or to any other party.</em></span></p> marcin@journalsmededu.pl (Marcin Kuzma) m.maslowski@mededu.pl (Marcin Masłowski) Wed, 12 Jun 2019 10:00:39 +0200 OJS http://blogs.law.harvard.edu/tech/rss 60 The young breast cancer patient therapy – new opportunities, new challenges https://journalsmededu.pl/index.php/OncoReview/article/view/412 <p class="description">The paper describes the case of a 31-year-old female patient with breast cancer with the abdominal metastases. This disease in young people usually has a more aggressive biological subtype, which significantly worsens the prognosis. In this patient aggressive treatment was used. It was effective and did not cause severe or long-term complications.</p> <div class="tagi blockquote">&nbsp;</div> Joanna Załuska-Kusz Copyright (c) https://journalsmededu.pl/index.php/OncoReview/article/view/412 Sun, 05 May 2019 00:00:00 +0200 A patient with lung cancer and increased right ventricular pressure – should all lung cancer patients be suspected of pulmonary embolism? https://journalsmededu.pl/index.php/OncoReview/article/view/413 <p>Lung cancer is associated with an increased risk of venous thromboembolism, including pulmonary embolism. In some situations, clinical deterioration in patients with lung cancer accompanied by elevated pressure in the right ventricle, usually measured by commonly used echocardiography, may support the diagnosis of pulmonary embolism. However, there are many other causes of increased pressure in the right ventricle in such patients, for example: progression of cancer, pre-existing lung diseases, surgical resection of pulmonary tissue, pnemotoxicity of radiotherapy or concomitant diseases of the left heart. The article presents 2 clinical cases of patients with lung cancer, in which elevated pressure in the right ventricle was resulted from other causes and accompanied the progression of cancer, despite the clinical picture suggesting a pulmonary embolism. Increased pressure in the right ventricle and usually associated pulmonary hypertension, significantly worsen already poor prognosis of patients with lung cancer. The differential diagnosis should, therefore, take into account the whole clinical picture, excluding venous thromboembolism as an important cause of pulmonary hypertension, but also take into account other potential factors to be able to make the right diagnosis and implement optimal treatment as early as possible.</p> Katarzyna Styczkiewicz Copyright (c) https://journalsmededu.pl/index.php/OncoReview/article/view/413 Sat, 01 Jun 2019 00:00:00 +0200